The next several weeks are shaping up as busy ones for Retraction Watch, as we make appearances in three cities: Continue reading Come see Retraction Watch in Calgary, Fort Collins, Montreal, New York, and Seattle
Author: Ivan Oransky
Oops: Math journal retracts paper accepted by “accidental administrative error”
Math journal editors can add — but they can also subtract.
That’s what happened to a 2012 paper in the Journal of Mathematical Analysis and Applications (JMAA), “On the fractional Ostrowski inequality with uncertainty.”
Here’s the notice: Continue reading Oops: Math journal retracts paper accepted by “accidental administrative error”
Duplicate publication of headache paper earns Expression of Concern, erratum
A 2003 paper is now subject to an Expression of Concern after its author reused a lot of its material in a 2007 paper.
Here’s the Expression of Concern for “New therapeutic target in primary headaches – blocking the CGRP receptor” by Lars Edvinsson of the University of Copehagen: Continue reading Duplicate publication of headache paper earns Expression of Concern, erratum
Researcher found by ORI to have committed misconduct earns back right to apply for Federal grants
![bois](http://www.retractionwatch.com/wp-content/uploads/2013/04/bois.jpg?w=100)
A former researcher at St. Jude Children’s Research Hospital in Memphis has won back the right to apply for Federal research funding despite a 2011 finding against him by the Office of Research Integrity (ORI).
Philippe Bois, a cancer researcher now working at the Scripps Research Institute in Florida, argued that the alleged misconduct in the ORI findings — which led to a three-year ban on applying for funding — was actually honest error. As Bois’s attorneys explained last year: Continue reading Researcher found by ORI to have committed misconduct earns back right to apply for Federal grants
University of Virginia doctoral candidate plagiarizes in business ethics journal, but remains in program
We’ve already reported on the retraction of a paper in a business ethics journal for plagiarism. Yes, plagiarism in an ethics journal. But it turns out there’s at least one more case of exactly the same thing, albeit in a different business ethics journal.
Here’s the notice from the Journal of Business Ethics: Continue reading University of Virginia doctoral candidate plagiarizes in business ethics journal, but remains in program
Retraction appears for former Case Western dermatology researcher found by ORI to have falsified data
Bryan William Doreian, who was found by the Office of Research Integrity (ORI) to have falsified data in his Case Western dissertation, has retracted a 2009 paper in Molecular Biology of the Cell also cited by the ORI.
Here’s the notice: Continue reading Retraction appears for former Case Western dermatology researcher found by ORI to have falsified data
Pfizer database errors cause two voluminous retractions for JACC statin-biomarker papers
Coding errors in a database maintained by Pfizer have led authors to retract two heart biomarker papers in the Journal of the American College of Cardiology.
The two notices, for “Prediction of cardiovascular events in statin-treated patients by lipid and non-lipid biomarkers” and “Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) Trial,” are highly detailed and say the same thing: Continue reading Pfizer database errors cause two voluminous retractions for JACC statin-biomarker papers
Two more Eric Smart retractions appear
![Eric J. Smart, via U Kentucky](http://retractionwatch.files.wordpress.com/2012/11/pic-eric-smart.jpg?w=114)
Eric Smart, the former University of Kentucky researcher found by the Office of Research Integrity to have faked images in ten papers, has two more retractions, both in the American Journal of Physiology — Cell Physiology.
Here’s one, for a paper cited four times, according to Thomson Scientific’s Web of Knowledge: Continue reading Two more Eric Smart retractions appear
Retraction 12 appears for Alirio Melendez, this one for plagiarism
The twelfth of Alirio Melendez’s 20-something retractions has appeared, in Clinical and Experimental Pharmacology and Physiology.
Along with the retraction notice, the journal runs letters from the paper’s two co-authors. Melendez writes: Continue reading Retraction 12 appears for Alirio Melendez, this one for plagiarism
ORI, OHRP find “some human subject issues” in Henschke lung cancer studies, but no evidence of misconduct
We have an update on two papers about lung cancer screening by Claudia Henschke and colleagues that were subject to an Expression of Concern early last year.
The original Expression of Concern in Cancer read, in part: Continue reading ORI, OHRP find “some human subject issues” in Henschke lung cancer studies, but no evidence of misconduct